Lupin (via Zydus) Co-marketed Zydus semaglutide metro and Tier 2 specialist reach 2,200/mo Format: Reusable multi-dose pen (Zydus device) identical product to Semaglyn/Mashema/Alterme Lupin holds semi-exclusive rights to co-market Zydus semaglutide under its own brands
In cisplatin and ischemiareperfusion models, vitamin D protects tubular cells by downregulating ferroptosis-related molecules, including acyl-CoA synthetase long-chain family member 4 (ACSL4) and prostaglandin-endoperoxide synthase 2 (PTGS2) (55)
The compound received marketing approval in China in June 2025 under the brand name Xinermei, making it the first domestically approved dual GLP-1/glucagon agonist anywhere in the world
Water isnt the only hydrating beverage
[1] Three molecules make up this antioxidant, namely cysteine, glycine, and glutamate
But there are still bad actors at the board determined to end our access